p53 Mediates Cellular Dysfunction and Behavioral Abnormalities in Huntington’s Disease
Top Cited Papers
- 1 July 2005
- Vol. 47 (1) , 29-41
- https://doi.org/10.1016/j.neuron.2005.06.005
Abstract
No abstract availableKeywords
Funding Information
- U.S. Public Health Service (DA-00074, DA-00266, EY08117, MH-069853)
- National Alliance for Research on Schizophrenia and Depression
- Huntington’s Disease Society of America
- Korea Foundation for Advanced Studies
- Hereditary Disease Foundation
This publication has 71 references indexed in Scilit:
- Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesisHuman Molecular Genetics, 2004
- Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal deathNature, 2004
- Nuclear-targeting of mutant huntingtin fragments produces Huntington's disease-like phenotypes in transgenic miceHuman Molecular Genetics, 2004
- Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and ApoptosisScience, 2004
- p53Cell, 2002
- Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutaminesNature Neuroscience, 2002
- The role of p53 in neuronal cell deathCell Death & Differentiation, 2000
- Inhibiting Caspase Cleavage of Huntingtin Reduces Toxicity and Aggregate Formation in Neuronal and Nonneuronal CellsJournal of Biological Chemistry, 2000
- Aggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in BrainScience, 1997
- Mitochondrial function in Huntington's disease: Clues for pathogenesis and prospects for treatmentAnnals of Neurology, 1997